Matches in Wikidata for { <http://www.wikidata.org/entity/Q91951865> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91951865 description "2019 թվականի մայիսի 11-ին հրատարակված գիտական հոդված" @default.
- Q91951865 description "article scientifique publié en 2019" @default.
- Q91951865 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91951865 description "scientific article published on 11 May 2019" @default.
- Q91951865 description "wetenschappelijk artikel" @default.
- Q91951865 description "наукова стаття, опублікована 11 травня 2019" @default.
- Q91951865 name "Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis" @default.
- Q91951865 name "Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis" @default.
- Q91951865 type Item @default.
- Q91951865 label "Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis" @default.
- Q91951865 label "Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis" @default.
- Q91951865 prefLabel "Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis" @default.
- Q91951865 prefLabel "Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis" @default.
- Q91951865 P1433 Q91951865-9C39ED66-CA08-4F2E-953C-DF0E218229F3 @default.
- Q91951865 P1476 Q91951865-F2C679CB-8612-4EC5-9C90-0B1A16AD835D @default.
- Q91951865 P2093 Q91951865-0DF46A43-425B-4E90-A44F-EB7D17A61B60 @default.
- Q91951865 P2093 Q91951865-1C4CD1CB-995B-430B-939F-E654F9B9B834 @default.
- Q91951865 P2093 Q91951865-F7C66254-8D01-4C2F-A5C7-134C3C8F752A @default.
- Q91951865 P304 Q91951865-0E783D57-8272-4AEF-8555-04A2C6C84151 @default.
- Q91951865 P31 Q91951865-909F6045-54CD-405C-9416-D7FA134548E1 @default.
- Q91951865 P356 Q91951865-7D4C5744-8DFB-4DCA-B0F7-7AD224653CE1 @default.
- Q91951865 P433 Q91951865-434CB1C8-D629-4060-AA4C-0B52DC69C39A @default.
- Q91951865 P478 Q91951865-A952BAC9-C109-44ED-AB9D-A650198C38F6 @default.
- Q91951865 P50 Q91951865-251D16FB-B66A-4C1B-8A88-DAA7D83B15C6 @default.
- Q91951865 P577 Q91951865-D064064E-8CBD-482B-89CF-9EA65F41F256 @default.
- Q91951865 P698 Q91951865-FAC0CD7F-D6A5-46EE-9E64-5C2D3161E946 @default.
- Q91951865 P356 JNNP-2019-320687 @default.
- Q91951865 P698 31079064 @default.
- Q91951865 P1433 Q1599804 @default.
- Q91951865 P1476 "Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis" @default.
- Q91951865 P2093 "Antonia Carroll" @default.
- Q91951865 P2093 "Jeremy Chataway" @default.
- Q91951865 P2093 "Wallace J Brownlee" @default.
- Q91951865 P304 "1376-1378" @default.
- Q91951865 P31 Q13442814 @default.
- Q91951865 P356 "10.1136/JNNP-2019-320687" @default.
- Q91951865 P433 "12" @default.
- Q91951865 P478 "90" @default.
- Q91951865 P50 Q91951860 @default.
- Q91951865 P577 "2019-05-11T00:00:00Z" @default.
- Q91951865 P698 "31079064" @default.